Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	The Word Brain 2015 – Free PDF | Print | Web A short guide to fast language learning	Free Abstracts

Autoimmune Disorders

Free Subscription Articles published in Arthritis Rheum Retrieve available abstracts of 251 articles: HTML format Text format

Single Articles

December 2013
1. DONG C, Ptacek TS, Redden DT, Zhang K, et al
   FcgammaRIIIa SNPs and haplotypes affect human IgG binding and association with lupus nephritis in African Americans.
   Arthritis Rheum. 2013 Dec 24. doi: 10.1002/art.38337.
   PubMed     Text format     Abstract available
   
   
   
2. HOBDAY PM, Auger JL, Schuneman GR, Haasken S, et al
   FcgammaRIII and IV on macrophages drive autoimmune valvular carditis.
   Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38311.
   PubMed     Text format     Abstract available
   
   
   
3. PARK JS, Kwok SK, Lim MA, Kim EK, et al
   STA-21, a promising STAT3 inhibitor that reciprocally regulates Th17 and Treg, inhibits osteoclastogenesis and alleviates autoimmune inflammation.
   Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38305.
   PubMed     Text format     Abstract available
   
   
   
4. OOMATIA A, Fang H, Petri M, Birnbaum J, et al
   Peripheral neuropathies in systemic lupus erythematosus (SLE): Clinical features, disease associations, and immunological characteristics evaluated over a 25-year study period.
   Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38302.
   PubMed     Text format     Abstract available
   
   
   
5. PARK MK, Park JS, Park EM, Lim MA, et al
   Halofuginone ameliorates autoimmune arthritis by regulating the balance between Th17 and regulatory T cells and inhibiting osteoclastogenesis.
   Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38313.
   PubMed     Text format     Abstract available
   
   
   
6. WILDE B, Dolff S, Witzke O, Damoiseaux J, et al
   Dysregulation of Treg cells in antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Free et al.
   Arthritis Rheum. 2013;65:3316.
   PubMed     Text format    
   
   
   
7. FREE ME, Su MA
   Reply.
   Arthritis Rheum. 2013;65:3316-8.
   PubMed     Text format    
   
   
   
8. YOUNG NA, Sharma R, Friedman AK, Kaffenberger BH, et al
   Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieu.
   Arthritis Rheum. 2013;65:3259-70.
   PubMed     Text format     Abstract available
   
   
   
9. AUDEMARD A, Bienvenu B, Magnier R, Fournier L, et al
   Clinical images: Bronchial stenosis in granulomatosis with polyangiitis (Wegener's).
   Arthritis Rheum. 2013;65:3303.
   PubMed     Text format    
   
   
   
10. WEHRENS EJ, Vastert SJ, Mijnheer G, Meerding J, et al
    Anti-tumor necrosis factor alpha targets protein kinase B/c-Akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritis.
    Arthritis Rheum. 2013;65:3279-84.
    PubMed     Text format     Abstract available
    
    
    November 2013
11. HIRAI T, Bussey M, Adams E
    Subscapular bursitis and calcinosis in a dermatomyositis patient.
    Arthritis Rheum. 2013 Nov 27. doi: 10.1002/art.38294.
    PubMed     Text format    
    
    
    
12. AGGARWAL R , Bandos A, Reed AM, Ascherman DP, et al
    Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38270.
    PubMed     Text format     Abstract available
    
    
    
13. MOON YM , Lee J, Lee SY, Her YM, et al
    Gene-associated retinoid-interferon-induced mortality 19 (GRIM-19) attenuates autoimmune arthritis by regulation of Th17 and Treg cells.
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38267.
    PubMed     Text format     Abstract available
    
    
    
14. GOLDSTEIN BL , Gedmintas L, Todd DJ
    Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of CTLA-4.
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38282.
    PubMed     Text format    
    
    
    
15. HANLY JG , Urowitz MB, O'Keeffe AG, Gordon C, et al
    Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
    Arthritis Rheum. 2013;65:2887-97.
    PubMed     Text format     Abstract available
    
    
    
16. LOCKSHIN MD
    Splitting headache (off).
    Arthritis Rheum. 2013;65:2759-61.
    PubMed     Text format    
    
    
    
17. ZHOU Y, Wu J, Kucik DF, White NB, et al
    Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils.
    Arthritis Rheum. 2013;65:2907-16.
    PubMed     Text format     Abstract available
    
    
    October 2013
18. LIM SS , Bayakly AR, Helmick CG, Gordon C, et al
    The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002-2004: The Georgia Lupus Registry.
    Arthritis Rheum. 2013 Oct 24. doi: 10.1002/art.38239.
    PubMed     Text format     Abstract available
    
    
    
19. SOMERS EC , Marder W, Cagnoli P, Lewis EE, et al
    Population-based incidence and prevalence of systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Program.
    Arthritis Rheum. 2013 Oct 24. doi: 10.1002/art.38238.
    PubMed     Text format     Abstract available
    
    
    
20. FREEDMAN BI , Langefeld CD, Andringa KK, Croker JA, et al
    End-stage kidney disease in African Americans with lupus nephritis associates with APOL1.
    Arthritis Rheum. 2013 Oct 21. doi: 10.1002/art.38220.
    PubMed     Text format     Abstract available
    
    
    
21. CORNETH OB , Mus AM, Asmawidjaja PS, Wolterink RG, et al
    Lack of IL-17 receptor A signaling prevents autoimmune inflammation of the joint and gives rise to a Th2-like phenotype in collagen-induced arthritis.
    Arthritis Rheum. 2013 Oct 14. doi: 10.1002/art.38229.
    PubMed     Text format     Abstract available
    
    
    
22. RINGOLD S, Weiss PF, Beukelman T, DeWitt EM, et al
    2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening amo
    Arthritis Rheum. 2013;65:2499-512.
    PubMed     Text format    
    
    
    
23. WIEDEMAN AE, Santer DM, Yan W, Miescher S, et al
    Contrasting mechanisms of interferon-alpha inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists.
    Arthritis Rheum. 2013;65:2713-23.
    PubMed     Text format     Abstract available
    
    
    
24. TSANTIKOS E, Maxwell MJ, Putoczki T, Ernst M, et al
    Interleukin-6 trans-signaling exacerbates inflammation and renal pathology in lupus-prone mice.
    Arthritis Rheum. 2013;65:2691-702.
    PubMed     Text format     Abstract available
    
    
    
25. EL-HALLAK M, Lovell D
    Pachydermodactyly mimicking juvenile idiopathic arthritis.
    Arthritis Rheum. 2013;65:2736.
    PubMed     Text format    
    
    
    September 2013
26. MCMAHON M , Skaggs BJ, Grossman J, Sahakian L, et al
    A panel of biomarkers is associated with increased risk for the presence and progression of atherosclerosis in women with Systemic Lupus Erythematosus.
    Arthritis Rheum. 2013 Sep 24. doi: 10.1002/art.38204.
    PubMed     Text format     Abstract available
    
    
    
27. ZHAO J , Wang H, Dai C, Wang H, et al
    P2X7 blockade attenuates lupus nephritis by inhibiting NLRP3/ASC/caspase-1 activation.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38174.
    PubMed     Text format     Abstract available
    
    
    
28. KHANNA D , Gladue H, Channick R, Chung L, et al
    Recommendations for screening and detection of connective-tissue disease associated pulmonary arterial hypertension.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38172.
    PubMed     Text format     Abstract available
    
    
    
29. ZHUANG H , Han S, Xu Y, Li Y, et al
    Toll-like receptor 7-stimulated tumor necrosis factor alpha causes bone marrow damage in systemic lupus erythematosus.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38189.
    PubMed     Text format     Abstract available
    
    
    
30. SMITH S , Gabhann JN, McCarthy E, Coffey B, et al
    Estrogen receptor alpha regulates TRIM21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38187.
    PubMed     Text format     Abstract available
    
    
    
31. FIORENTINO DF , Chung LS, Christopher-Stine L, Zaba L, et al
    Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1-gamma.
    Arthritis Rheum. 2013 Sep 3. doi: 10.1002/art.38093.
    PubMed     Text format     Abstract available
    
    
    
32. ASCASO FJ, Rodriguez NA, San Miguel R, Huerva V, et al
    The "flying saucer" sign on spectral domain optical coherence tomography in chloroquine retinopathy.
    Arthritis Rheum. 2013;65:2322.
    PubMed     Text format    
    
    
    
33. TRIGUNAITE A, Khan A, Der E, Song A, et al
    Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.
    Arthritis Rheum. 2013;65:2392-402.
    PubMed     Text format     Abstract available
    
    
    
34. MILOSLAVSKY EM, Specks U, Merkel PA, Seo P, et al
    Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
    Arthritis Rheum. 2013;65:2441-9.
    PubMed     Text format     Abstract available
    
    
    
35. LOVELL DJ, Giannini EH, Reiff AO, Kimura Y, et al
    Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.
    Arthritis Rheum. 2013;65:2486-96.
    PubMed     Text format     Abstract available
    
    
    
36. XIE G, Roshandel D, Sherva R, Monach PA, et al
    Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.
    Arthritis Rheum. 2013;65:2457-68.
    PubMed     Text format     Abstract available
    
    
    
37. CASTELLANOS GONZALEZ M, Sanchez Barrueco A, Esther Joven B
    Bilateral ulcers on the face as a manifestation of granulomatosis with polyangiitis (Wegener's).
    Arthritis Rheum. 2013;65:2367.
    PubMed     Text format    
    
    
    August 2013
38. JENKS SA , Palmer E, Marin E, Hartson L, et al
    9G4+ auto-antibodies are an important source of apoptotic cell reactivity associated with high disease activity in systemic lupus erythematosus.
    Arthritis Rheum. 2013 Aug 27. doi: 10.1002/art.38138.
    PubMed     Text format     Abstract available
    
    
    
39. MILLER FW , Cooper RG, Vencovsky J, Rider LG, et al
    Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.
    Arthritis Rheum. 2013 Aug 27. doi: 10.1002/art.38137.
    PubMed     Text format     Abstract available
    
    
    
40. MURTHY V , Willis R, Romay-Penabad Z, Ruiz-Limon P, et al
    Value of isolated IgA anti-beta GPI positivity in the diagnosis of the antiphospholipid syndrome.
    Arthritis Rheum. 2013 Aug 27. doi: 10.1002/art.38131.
    PubMed     Text format     Abstract available
    
    
    
41. GOLDING A , Hasni S, Illei G, Shevach EM, et al
    The percentage of Foxp3 Helios T regulatory cells positively correlates with disease activity in systemic lupus erythematosus.
    Arthritis Rheum. 2013 Aug 7. doi: 10.1002/art.38119.
    PubMed     Text format     Abstract available
    
    
    
42. CARRUTHERS MN , Miloslavsky EM, Stone JH
    Reply.
    Arthritis Rheum. 2013;65:2217-8.
    PubMed     Text format    
    
    
    
43. FATEMI G , Fang MA
    IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al.
    Arthritis Rheum. 2013;65:2217.
    PubMed     Text format    
    
    
    
44. KIM JY , Park YJ, Kim KJ, Choi JJ, et al
    Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress.
    Arthritis Rheum. 2013;65:2172-82.
    PubMed     Text format     Abstract available
    
    
    
45. OKADA Y , Plenge RM
    Editorial: entering the age of whole-exome sequencing in rheumatic diseases: novel insights into disease pathogenicity.
    Arthritis Rheum. 2013;65:1975-9.
    PubMed     Text format    
    
    
    July 2013
46. SZEPIETOWSKI JC , Nilganuwong S, Wozniacka A, Kuhn A, et al
    Phase 1, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
    Arthritis Rheum. 2013 Jul 29. doi: 10.1002/art.38091.
    PubMed     Text format     Abstract available
    
    
    
47. KSHIRSAGAR S , Binder E, Riedl M, Wechselberger G, et al
    Enhanced activity of Akt in effector T cells from children with lupus nephritis is associated with reduced induction of TRAF6 and increase in OX40.
    Arthritis Rheum. 2013 Jul 29. doi: 10.1002/art.38089.
    PubMed     Text format     Abstract available
    
    
    
48. PERERA J , Liu X, Zhou Y, Joseph NE, et al
    Insufficient autoantigen presentation and failure of tolerance in a mouse model of rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 9. doi: 10.1002/art.38085.
    PubMed     Text format     Abstract available
    
    
    
49. CARTER LM , Isenberg DA, Ehrenstein MR
    Elevated serum B-cell activating factor (BAFF / BLyS) is associated with rising anti-dsDNA antibody levels and flare following B-cell depletion therapy in systemic lupus erythematosus.
    Arthritis Rheum. 2013 Jul 9. doi: 10.1002/art.38074.
    PubMed     Text format     Abstract available
    
    
    
50. WANG JH , New JS, Xie S, Yang P, et al
    Development of autoantibodies due to regulator of G-protein signaling 13-induced delay in Germinal center B cell differentiation to plasmablasts.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38059.
    PubMed     Text format     Abstract available
    
    
    
51. WILLIS VC , Demoruelle MK, Derber LA, Chartier-Logan CJ, et al
    Sputa autoantibodies in patients with established rheumatoid arthritis and subjects at-risk for future clinically apparent disease.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38066.
    PubMed     Text format     Abstract available
    
    
    
52. OSTERGAARD O , Nielsen CT, Iversen LV, Tanassi JT, et al
    Unique protein signature of circulating microparticles in systemic lupus erythematosus.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38065.
    PubMed     Text format     Abstract available
    
    
    
53. FREE ME , Bunch DO, McGregor JA, Jones BE, et al
    Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population.
    Arthritis Rheum. 2013;65:1922-33.
    PubMed     Text format     Abstract available
    
    
    
54. LEE SW , Park KH, Park S, Kim JH, et al
    Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
    Arthritis Rheum. 2013;65:1902-12.
    PubMed     Text format     Abstract available
    
    
    
55. PETRI M , Bello KJ, Fang H, Magder LS, et al
    Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio.
    Arthritis Rheum. 2013;65:1865-71.
    PubMed     Text format     Abstract available
    
    
    June 2013
56. ANYANWU CO , Ang CC, Werth VP
    Oral mucosal involvement of Bullous Systemic Lupus Erythematosus.
    Arthritis Rheum. 2013 Jun 18. doi: 10.1002/art.38051.
    PubMed     Text format    
    
    
    
57. MOK C , Kwok RC, Yip PS
    Effect of renal disease on standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus.
    Arthritis Rheum. 2013 Jun 10. doi: 10.1002/art.38006.
    PubMed     Text format     Abstract available
    
    
    
58. PETRI MA , van Vollenhoven RF, Buyon J, Levy RA, et al
    Baseline predictors of systemic lupus erythematosus flares: Data from the combined placebo groups in the Phase 3 belimumab trials.
    Arthritis Rheum. 2013 Jun 10. doi: 10.1002/art.37995.
    PubMed     Text format     Abstract available
    
    
    
59. MINA-OSORIO P , Lastant J, Keirstead N, Whittard T, et al
    Suppression of glomerulonephritis in lupus prone NZB/W mice by RN486, a selective inhibitor of Bruton's Tyrosine Kinase.
    Arthritis Rheum. 2013 Jun 10. doi: 10.1002/art.38047.
    PubMed     Text format     Abstract available
    
    
    
60. BALBONI I , Niewold TB, Morgan G, Limb C, et al
    Detection of anti-Ro, La, Smith and RNP autoantibodies by autoantigen microarray analysis and interferon-alpha induction in juvenile dermatomyositis.
    Arthritis Rheum. 2013 Jun 5. doi: 10.1002/art.38038.
    PubMed     Text format     Abstract available
    
    
    
61. MYSLER EF , Spindler AJ, Guzman R, Bijl M, et al
    Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results from the Randomized, Double-Blind Phase III BELONG Study.
    Arthritis Rheum. 2013 Jun 5. doi: 10.1002/art.38037.
    PubMed     Text format     Abstract available
    
    
    
62. LIU Y , Dong J, Mu R, Gao Y, et al
    MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn.
    Arthritis Rheum. 2013;65:1603-11.
    PubMed     Text format     Abstract available
    
    
    May 2013
63. CUTTNER J , Spiera H, Gorevic P
    Rituximab in refractory and relapsed dermatomyositis and polymyositis: Comment on the article by Oddis et al.
    Arthritis Rheum. 2013 May 17. doi: 10.1002/art.38018.
    PubMed     Text format    
    
    
    
64. GITELMAN DR , Klein-Gitelman MS, Ying J, Sagcal-Gironella AC, et al
    Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit.
    Arthritis Rheum. 2013 May 10. doi: 10.1002/art.38009.
    PubMed     Text format     Abstract available
    
    
    
65. BELOT A , Kasher PR, Trotter EW, Foray AP, et al
    Protein kinase C delta deficiency causes mendelian systemic lupus erythematosus with B-cell defective apoptosis and hyperproliferation.
    Arthritis Rheum. 2013 May 10. doi: 10.1002/art.38008.
    PubMed     Text format     Abstract available
    
    
    
66. JIN JO , Kawai T, Cha S, Yu Q, et al
    Interleukin-7 enhances Th1 response to promote the development of Sjogren's Syndrome-Like autoimmune exocrinopathy.
    Arthritis Rheum. 2013 May 10. doi: 10.1002/art.38007.
    PubMed     Text format     Abstract available
    
    
    
67. SHAH M , Targoff IN, Rice MM, Miller FW, et al
    Ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in Juvenile Myositis.
    Arthritis Rheum. 2013 May 8. doi: 10.1002/art.37985.
    PubMed     Text format     Abstract available
    
    
    
68. HTUN P , Horger M, Gawaz M, Fateh-Moghadam S, et al
    Giant coronary artery aneurysms and eosinophilic granulomatosis with polyangiitis.
    Arthritis Rheum. 2013;65:1406.
    PubMed     Text format    
    
    
    
69. HAQUE S , Rakieh C, Marriage F, Ho P, et al
    Shortened telomere length in patients with systemic lupus erythematosus.
    Arthritis Rheum. 2013;65:1319-23.
    PubMed     Text format     Abstract available
    
    
    
70. GARCIA RJ , Francis L, Dawood M, Lai ZW, et al
    Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.
    Arthritis Rheum. 2013;65:1313-8.
    PubMed     Text format     Abstract available
    
    
    April 2013
71. MOLD C , Du Clos TW
    C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.
    Arthritis Rheum. 2013 Apr 10. doi: 10.1002/art.37968.
    PubMed     Text format     Abstract available
    
    
    
72. STRICKLAND FM , Hewagama A, Wu A, Sawalha AH, et al
    Diet influences expression of autoimmune associated genes and disease severity by epigenetic mechanisms in a transgenic lupus model.
    Arthritis Rheum. 2013 Apr 10. doi: 10.1002/art.37967.
    PubMed     Text format     Abstract available
    
    
    
73. LOCKSHIN MD , Cohn E, Aslam A, Buyon JP, et al
    Reply.
    Arthritis Rheum. 2013;65:1129-30.
    PubMed     Text format    
    
    
    
74. OLEKSYN D , Pulvino M, Zhao J, Misra R, et al
    Protein kinase Cbeta is required for lupus development in Sle mice.
    Arthritis Rheum. 2013;65:1022-31.
    PubMed     Text format     Abstract available
    
    
    
75. SHASHIDHARAMURTHY R , Machiah D, Aitken JD, Putty K, et al
    Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice.
    Arthritis Rheum. 2013;65:1064-73.
    PubMed     Text format     Abstract available
    
    
    March 2013
76. WOFSY D , Hillson JL, Diamond B
    Comparison of alternative primary outcome measures for use in a lupus nephritis trial.
    Arthritis Rheum. 2013 Mar 25. doi: 10.1002/art.37940.
    PubMed     Text format     Abstract available
    
    
    
77. ISGRO J , Gupta S, Jacek E, Pavri T, et al
    Enhanced ROCK activation in patients with systemic lupus erythematosus.
    Arthritis Rheum. 2013 Mar 18. doi: 10.1002/art.37934.
    PubMed     Text format     Abstract available
    
    
    
78. SIEGER N , Fleischer SJ, Mei HE, Reiter K, et al
    CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation.
    Arthritis Rheum. 2013;65:770-9.
    PubMed     Text format     Abstract available
    
    
    
79. FAURSCHOU M , Westman K, Rasmussen N, de Groot K, et al
    Reply.
    Arthritis Rheum. 2013;65:844.
    PubMed     Text format    
    
    
    
80. LANGFORD CA , Hoffman GS
    Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al.
    Arthritis Rheum. 2013;65:843.
    PubMed     Text format    
    
    
    
81. ICHINOSE K , Zhang Z, Koga T, Juang YT, et al
    Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.
    Arthritis Rheum. 2013;65:764-9.
    PubMed     Text format     Abstract available
    
    
    February 2013
82. URBONAVICIUTE V , Starke C, Pirschel W, Pohle S, et al
    Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Arthritis Rheum. 2013 Feb 28. doi: 10.1002/art.37914.
    PubMed     Text format     Abstract available
    
    
    
83. DEMORUELLE MK , Deane KD
    Reply to Geradi and colleagues regarding RA-related autoantibodies and lung disease.
    Arthritis Rheum. 2013 Feb 22. doi: 10.1002/art.37904.
    PubMed     Text format    
    
    
    
84. CARLSEN AL , Schetter AJ, Nielsen CT, Lood C, et al
    Circulating microRNA expression profiles associated with systemic lupus erythematosus.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37890.
    PubMed     Text format     Abstract available
    
    
    
85. HARLOW L , Rosas IO, Gochuico BR, Mikuls TR, et al
    Identification of citrullinated heat shock protein 90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37881.
    PubMed     Text format     Abstract available
    
    
    
86. DEANE KD , Nicolls MR
    Developing better biomarkers for connective tissue disease-associated interstitial lung disease: Citrullinated HSP-90 autoantibodies in rheumatoid arthritis.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37878.
    PubMed     Text format    
    
    
    
87. PETRI M , Wallace DJ, Spindler A, Chindalore V, et al
    Sifalimumab, a human anti-interferon-a monoclonal antibody, in systemic lupus erythematosus: A phase 1 randomized controlled, dose-escalation study.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37824.
    PubMed     Text format     Abstract available
    
    
    
88. AL-MAINI M , Jeyalingam T, Brown P, Lee JJ, et al
    A hot spot for systemic lupus erythematosus but not for psoriatic arthritis identified by spatial analysis suggests an interaction between race and place of residence.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37897.
    PubMed     Text format     Abstract available
    
    
    
89. LUIS CG
    Antineutrophil cytoplasmic autoantibodies: An unbiased and efficient tool to classify renal vasculitis? Comment on the article by Lionaki et al.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37892.
    PubMed     Text format    
    
    
    
90. ZIEGLER A , Uchanska-Ziegler B, Blaschitz A, Hutter H, et al
    Expression of free HLA class I heavy chains in an immune-privileged site: comment on the article by Taurog et al.
    Arthritis Rheum. 2013;65:540-1.
    PubMed     Text format    
    
    
    
91. TAUROG JD
    Reply: Expression of free HLA class I heavy chains in an immune-privileged site: comment on the article by Taurog et al.
    Arthritis Rheum. 2013;65:541.
    PubMed     Text format    
    
    
    January 2013
92. KIM JH , Jung SH, Bae JS, Lee HS, et al
    Deletion variants of RABGAP1L, 10q21.3 and C4 are associated with the risk of systemic lupus erythematosus in Korean women.
    Arthritis Rheum. 2013 Jan 17. doi: 10.1002/art.37854.
    PubMed     Text format     Abstract available
    
    
    
93. VINET E , Bernatsky S, Pineau CA, Clarke AE, et al
    Increased male-to-female ratio in children born to women with systemic lupus erythematosus.
    Arthritis Rheum. 2013 Jan 17. doi: 10.1002/art.37852.
    PubMed     Text format    
    
    
    
94. CORBERA-BELLALTA M , Planas-Rigol E, Espigol-Frigole G, Lozano E, et al
    Functionally relevant regulatory T cells are present in giant-cell arteritis lesions. Comment on the paper by Samson et al.
    Arthritis Rheum. 2013 Jan 17. doi: 10.1002/art.37865.
    PubMed     Text format    
    
    
    
95. JACOB CO , Yu N, Guo S, Jacob N, et al
    Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
    Arthritis Rheum. 2013 Jan 17. doi: 10.1002/art.37846.
    PubMed     Text format     Abstract available
    
    
    
96. SAMSON M , Janikashvili N, Martin L, Audia S, et al
    REPLY TO THE LETTER: "Functionally relevant regulatory T cells are present in Giant-Cell Arteritis lesions."
    Arthritis Rheum. 2013 Jan 17. doi: 10.1002/art.37863.
    PubMed     Text format    
    
    
    
97. COMARMOND C , Pagnoux C, Khellaf M, Cordier JF, et al
    Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
    Arthritis Rheum. 2013;65:270-81.
    PubMed     Text format     Abstract available
    
    
    December 2012
98. ELORANTA ML , Alm GV, Ronnblom L
    Plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.
    Arthritis Rheum. 2012 Dec 28. doi: 10.1002/art.37821.
    PubMed     Text format    
    
    
    
99. SHAO X , Yang R, Yan M, Li Y, et al
    Inducible expression of kallikrein in renal tubular cells protect mice from spontaneous lupus nephritis.
    Arthritis Rheum. 2012 Dec 28. doi: 10.1002/art.37798.
    PubMed     Text format     Abstract available
    
    
    
100. PARK JS , Lim MA, Cho ML, Ryu JG, et al
     p53 controls autoimmune arthritis via the STAT3/STAT5-mediated regulation of the Th17-Treg balance.
     Arthritis Rheum. 2012 Dec 28. doi: 10.1002/art.37841.
     PubMed     Text format     Abstract available
     
     
     
101. GOMEZ-MARTIN D , Ibarra-Sanchez M, Romo-Tena J, Cruz-Ruiz J, et al
     Casitas B-lineage-lymphoma-b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
     Arthritis Rheum. 2012 Dec 21. doi: 10.1002/art.37833.
     PubMed     Text format     Abstract available
     
     
     
102. LIAO KP , Kurreeman F, Li G, Duclos G, et al
     Autoantibodies, autoimmune risk alleles and clinical associations in rheumatoid arthritis cases and non-RA controls in the electronic medical records.
     Arthritis Rheum. 2012 Dec 10. doi: 10.1002/art.37801.
     PubMed     Text format     Abstract available
     
     
     
103. RAJASEKARAN N , Wang N, Truong P, Rinderknecht C, et al
     Host-derived CD4(+) T cells attenuate stem cell mediated transfer of autoimmune arthritis in lethally irradiated B6.g7 mice.
     Arthritis Rheum. 2012 Dec 10. doi: 10.1002/art.37800.
     PubMed     Text format     Abstract available
     
     
     
104. REN T , Ho RC, Mak A
     Dysfunctional cortico-basal ganglia-thalamic circuit and altered hippocampal-amygdala activity on cognitive set-shifting in non-neuropsychiatric systemic lupus erythematosus.
     Arthritis Rheum. 2012;64:4048-59.
     PubMed     Text format     Abstract available
     
     
     
105. YUAN F , Nelson RK, Tabor DE, Zhang Y, et al
     Dexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB x NZW)F1 mice without causing systemic side effects.
     Arthritis Rheum. 2012;64:4029-39.
     PubMed     Text format     Abstract available
     
     
     
106. RAMOS PS , Marion MC, Langefeld CD, Buyon JP, et al
     Brief report: enrichment of associations in genes with fibrosis, apoptosis, and innate immunity functions with cardiac manifestations of neonatal lupus.
     Arthritis Rheum. 2012;64:4060-5.
     PubMed     Text format     Abstract available
     
     
     November 2012
107. LAUWERYS BR , Hachulla E, Spertini F, Lazaro E, et al
     Down-regulation of Interferon signature in systemic lupus erythematosus patients by active immunization with Interferon alpha-Kinoid.
     Arthritis Rheum. 2012 Nov 30. doi: 10.1002/art.37785.
     PubMed     Text format     Abstract available
     
     
     
108. FELDMAN CH , Hiraki LT, Liu J, Fischer MA, et al
     Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among U.S. adults with medicaid coverage, 2000-2004.
     Arthritis Rheum. 2012 Nov 30. doi: 10.1002/art.37795.
     PubMed     Text format     Abstract available
     
     
     
109. DE VISSER M
     Editorial on manuscript by oddis et al.: Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial.
     Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37758.
     PubMed     Text format    
     
     
     
110. ODDIS CV , Reed AM, Aggarwal R, Rider LG, et al
     Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial.
     Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37754.
     PubMed     Text format     Abstract available
     
     
     
111. KAISER R , Taylor KE, Deng Y, Zhao J, et al
     SNPs in VKORC1 are risk factors for systemic lupus erythematosus in asians.
     Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37751.
     PubMed     Text format     Abstract available
     
     
     
112. IGLESIAS M , Postigo J, Santiuste I, Gonzalez J, et al
     p27(kip1) inhibits systemic autoimmunity through the control of regulatory T cell activity and differentiation.
     Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37778.
     PubMed     Text format     Abstract available
     
     
     
113. ERKAN D , Vega J, Ramon G, Kozora E, et al
     A pilot open label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
     Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37759.
     PubMed     Text format     Abstract available
     
     
     
114. BRUNER BF , Guthridge JM, Lu R, Vidal G, et al
     Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
     Arthritis Rheum. 2012;64:3677-86.
     PubMed     Text format     Abstract available
     
     
     
115. ABUD-MENDOZA C , Herrera-Van Oostdam DA
     Concomitant therapy with statins and immunosuppressive agents in childhood primary angiitis of the central nervous system: comment on the article by Cellucci et al.
     Arthritis Rheum. 2012;64:3820-1.
     PubMed     Text format    
     
     
     
116. NAKAZAWA D , Tomaru U, Suzuki A, Masuda S, et al
     Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vascu
     Arthritis Rheum. 2012;64:3779-87.
     PubMed     Text format     Abstract available
     
     
     
117. RADIC M , Kaplan MJ
     Jumbled NETs promote vasculitis.
     Arthritis Rheum. 2012;64:3498-501.
     PubMed     Text format    
     
     
     
118. CARTIN-CEBA R , Golbin JM, Keogh KA, Peikert T, et al
     Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
     Arthritis Rheum. 2012;64:3770-8.
     PubMed     Text format     Abstract available
     
     
     
119. SMITH RM , Jones RB, Guerry MJ, Laurino S, et al
     Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
     Arthritis Rheum. 2012;64:3760-9.
     PubMed     Text format     Abstract available
     
     
     October 2012
120. YOSHIO T , Okamoto H, Md SH, Minota S, et al
     Anti-NR2 glutamate receptor auto-IgG antibodies from patients with systemic lupus erythematosus activate endothelial cells.
     Arthritis Rheum. 2012 Oct 10. doi: 10.1002/art.37745.
     PubMed     Text format     Abstract available
     
     
     
121. DROUIN EE , Seward RJ, Strle K, McHugh G, et al
     A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.
     Arthritis Rheum. 2012 Oct 8. doi: 10.1002/art.37732.
     PubMed     Text format     Abstract available
     
     
     
122. MOK C , Chan P, To C
     Anti-mullerian hormone and ovarian reserve in systemic lupus erythematosus.
     Arthritis Rheum. 2012 Oct 8. doi: 10.1002/art.37719.
     PubMed     Text format     Abstract available
     
     
     
123. LOCKSHIN MD , Cohn E, Aslam A, Buyon JP, et al
     Sex ratios of children of lupus pregnancies.
     Arthritis Rheum. 2012 Oct 8. doi: 10.1002/art.37718.
     PubMed     Text format    
     
     
     
124. LIONAKI S , Blyth ER, Hogan SL, Hu Y, et al
     Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
     Arthritis Rheum. 2012;64:3452-62.
     PubMed     Text format     Abstract available
     
     
     
125. RICHMAN IB , Taylor KE, Chung SA, Trupin L, et al
     European genetic ancestry is associated with a decreased risk of lupus nephritis.
     Arthritis Rheum. 2012;64:3374-82.
     PubMed     Text format     Abstract available
     
     
     
126. STONE JH , Khosroshahi A, Deshpande V, Chan JK, et al
     Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.
     Arthritis Rheum. 2012;64:3061-7.
     PubMed     Text format    
     
     
     
127. YE Z , Jiang Z, Jiang Y
     Mycophenolate mofetil in the treatment of systemic lupus erythematosus: Comment on the article by Hervier et al.
     Arthritis Rheum. 2012;64:3489.
     PubMed     Text format    
     
     
     
128. FAURSCHOU M , Westman K, Rasmussen N, de Groot K, et al
     Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
     Arthritis Rheum. 2012;64:3472-7.
     PubMed     Text format     Abstract available
     
     
     September 2012
129. FERNANDEZ-FERNANDEZ FJ
     "Regulatory T cells in giant cell arteritis: Might they be another target for adjuvant treatment ?"
     Arthritis Rheum. 2012 Sep 22. doi: 10.1002/art.37700.
     PubMed     Text format    
     
     
     
130. SAMSON M , Bonnotte B
     Reply to the letter: "Regulatory T cells in giant cell arteritis: Might there be another target for adjuvant treatment?"
     Arthritis Rheum. 2012 Sep 22. doi: 10.1002/art.37699.
     PubMed     Text format    
     
     
     
131. SCHONERMARCK U , Rau S, Fischereder M
     How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al.
     Arthritis Rheum. 2012;64:3057-8.
     PubMed     Text format    
     
     
     
132. TAROUMIAN S , Naylor SM, Ben-Artzi A
     Clinical Images: ultrasonographic appearance of thyroid acropachy.
     Arthritis Rheum. 2012;64:3033.
     PubMed     Text format    
     
     
     
133. THACKER SG , Zhao W, Smith CK, Luo W, et al
     Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.
     Arthritis Rheum. 2012;64:2975-85.
     PubMed     Text format     Abstract available
     
     
     
134. GORELIK GJ , Yarlagadda S, Richardson BC
     Protein kinase Cdelta oxidation contributes to ERK inactivation in lupus T cells.
     Arthritis Rheum. 2012;64:2964-74.
     PubMed     Text format     Abstract available
     
     
     
135. LAI ZW , Hanczko R, Bonilla E, Caza TN, et al
     N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
     Arthritis Rheum. 2012;64:2937-46.
     PubMed     Text format     Abstract available
     
     
     August 2012
136. SCHOEB TR , Jarmi T, Hicks MJ, Henke S, et al
     eNOS inhibits the development of autoimmune-mediated vasculitis.
     Arthritis Rheum. 2012 Aug 29. doi: 10.1002/art.37683.
     PubMed     Text format     Abstract available
     
     
     
137. MAVRAGANI CP , Schini M, Gravani F, Kaltsas G, et al
     Adrenal autoimmunity in primary Sjogren's syndrome.
     Arthritis Rheum. 2012 Aug 29. doi: 10.1002/art.34679.
     PubMed     Text format     Abstract available
     
     
     
138. WERNER JL , Christopher-Stine L, Ghazarian SR, Pak KS, et al
     Antibody levels correlate with creatine kinase levels and strength in anti-HMG-CoA reductase-associated autoimmune myopathy.
     Arthritis Rheum. 2012 Aug 29. doi: 10.1002/art.34673.
     PubMed     Text format     Abstract available
     
     
     
139. PETRI M , Purvey S, Fang H, Magder LS, et al
     Predictors of organ damage in systemic lupus erythematosus: The hopkins' lupus cohort.
     Arthritis Rheum. 2012 Aug 29. doi: 10.1002/art.34672.
     PubMed     Text format     Abstract available
     
     
     
140. KALUNIAN KC , Chatham WW, Massarotti EM, Reyes-Thomas J, et al
     Measurements of cell bound complement activation products enhance diagnostic performance in systemic lupus erythematosus.
     Arthritis Rheum. 2012 Aug 29. doi: 10.1002/art.34669.
     PubMed     Text format     Abstract available
     
     
     
141. SANCHEZ E , Rasmussen A, Riba L, Acevedo E, et al
     Impact of genetic ancestry and socio-demographic status on the clinical expression of systemic lupus erythematosus in Amerindian-European populations.
     Arthritis Rheum. 2012 Aug 8. doi: 10.1002/art.34650.
     PubMed     Text format     Abstract available
     
     
     
142. BENNETT TD , Fluchel M, Hersh AO, Hayward KN, et al
     Macrophage activation syndrome in children with systemic lupus erythematosus and juvenile idiopathic arthritis.
     Arthritis Rheum. 2012 Aug 8. doi: 10.1002/art.34661.
     PubMed     Text format     Abstract available
     
     
     
143. REED AM , Peterson E, Bilgic H, Ytterberg SR, et al
     Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course.
     Arthritis Rheum. 2012 Aug 8. doi: 10.1002/art.34659.
     PubMed     Text format     Abstract available
     
     
     
144. GONO T , Kawaguchi Y, Kuwana M, Sugiura T, et al
     HLA-DRB1*0101/*0405 is associated with susceptibility to Anti-MDA5 antibody-positive dermatomyositis in the Japanese population.
     Arthritis Rheum. 2012 Aug 8. doi: 10.1002/art.34657.
     PubMed     Text format     Abstract available
     
     
     
145. HIRAKI LT , Feldman CH, Liu J, Alarcon GS, et al
     Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US medicaid beneficiary population.
     Arthritis Rheum. 2012;64:2669-76.
     PubMed     Text format     Abstract available
     
     
     
146. ROGGENBUCK D , Egerer K, Feist E, Burmester GR, et al
     Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al.
     Arthritis Rheum. 2012;64:2807-8.
     PubMed     Text format    
     
     
     
147. FOX DA
     Treg cells to the rescue.
     Arthritis Rheum. 2012;64:2426-8.
     PubMed     Text format    
     
     
     
148. LOOD C , Allhorn M, Lood R, Gullstrand B, et al
     IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?
     Arthritis Rheum. 2012;64:2698-706.
     PubMed     Text format     Abstract available
     
     
     July 2012
149. MCBRIDE JM , Jiang J, Abbas AR, Morimoto A, et al
     Safety and pharmacodynamic results of rontalizumab in a phase i, placebo controlled, double blind, dose escalation study in systemic lupus erythematosus.
     Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34632.
     PubMed     Text format     Abstract available
     
     
     
150. SAMSON M , Audia S, Fraszczak J, Trad M, et al
     Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
     Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34647.
     PubMed     Text format     Abstract available
     
     
     
151. ADRIANTO I , Wang S, Wiley GB, Lessard CJ, et al
     Two independent functional risk haplotypes in TNIP1 are associated with systemic lupus erythematosus.
     Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34642.
     PubMed     Text format     Abstract available
     
     
     
152. WOFSY D , Hillson JL, Diamond B
     Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions.
     Arthritis Rheum. 2012 Jul 17. doi: 10.1002/art.34624.
     PubMed     Text format     Abstract available
     
     
     
153. KIROU KA , Gkrouzman E, Chevalier JM, Seshan SV, et al
     Anti-inflammatory strategies, not just B cell depletion, is required for optimal therapy of severe proliferative lupus nephritis. comment on the article by Rovin et al.
     Arthritis Rheum. 2012 Jul 6. doi: 10.1002/art.34617.
     PubMed     Text format    
     
     
     
154. ROVIN BH
     Author response to the commentary: Anti-inflammatory strategies, not just B cell depletion, is required for optimal therapy of severe proliferative lupus nephritis.
     Arthritis Rheum. 2012 Jul 6. doi: 10.1002/art.34616.
     PubMed     Text format    
     
     
     
155. WATSON L , Leone V, Pilkington C, Tullus K, et al
     Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
     Arthritis Rheum. 2012;64:2356-65.
     PubMed     Text format     Abstract available
     
     
     June 2012
156. KIM E , Cook-Mills J, Morgan G, Sredni ST, et al
     Increased VCAM-1 expression in short duration, untreated juvenile dermatomyositis muscle biopsies is regulated by miR-126.
     Arthritis Rheum. 2012 Jun 27. doi: 10.1002/art.34606.
     PubMed     Text format     Abstract available
     
     
     
157. VANHECKE D , Roumenina LT, Wan H, Osthoff M, et al
     Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based assay.
     Arthritis Rheum. 2012 Jun 27. doi: 10.1002/art.34605.
     PubMed     Text format     Abstract available
     
     
     
158. TSOKOS GC , Thai TH
     Interleukin 2 in systemic autoimmunity hits the micro way.
     Arthritis Rheum. 2012 Jun 26. doi: 10.1002/art.34597.
     PubMed     Text format    
     
     
     
159. FAN W , Liang D, Tang Y, Qu B, et al
     Identification of microRNA-31 as a novel regulator contributing to impaired IL-2 production in T cells from patients with systemic lupus erythematosus.
     Arthritis Rheum. 2012 Jun 26. doi: 10.1002/art.34596.
     PubMed     Text format     Abstract available
     
     
     
160. MIKULS TR , Thiele GM, Deane KD, Payne JB, et al
     Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk for future rheumatoid arthritis.
     Arthritis Rheum. 2012 Jun 26. doi: 10.1002/art.34595.
     PubMed     Text format     Abstract available
     
     
     
161. RHEE RL , Baker J
     Anti-p155 autoantibodies as a diagnostic marker for cancer-associated dermatomyositis: Comment on the article by Trallero-Araguas et al.
     Arthritis Rheum. 2012 Jun 21. doi: 10.1002/art.34579.
     PubMed     Text format    
     
     
     
162. RODRIGO-PENDAS J , Trallero-Araguas E, Martinez-Gomez X, Selva-O'Callaghan A, et al
     Anti-p155 autoantibodies as a diagnostic marker for cancer associated dermatomyositis.
     Arthritis Rheum. 2012 Jun 21. doi: 10.1002/art.34577.
     PubMed     Text format    
     
     
     
163. MERRILL JT , Ginzler EM, Wallace DJ, McKay JD, et al
     Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
     Arthritis Rheum. 2012 Jun 5. doi: 10.1002/art.34564.
     PubMed     Text format     Abstract available
     
     
     
164. WANG M , Xie H, Shrestha S, Sredni S, et al
     Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsies from untreated juvenile dermatomyositis suggests self-renewal capacity.
     Arthritis Rheum. 2012 Jun 5. doi: 10.1002/art.34573.
     PubMed     Text format     Abstract available
     
     
     
165. BETHUNAICKAN R , Sahu R, Liu Z, Tang YT, et al
     Anti-TNF treatment of IFN induced lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.
     Arthritis Rheum. 2012 Jun 5. doi: 10.1002/art.34553.
     PubMed     Text format     Abstract available
     
     
     
166. CHERIAN TS , Kariuki SN, Franek BS, Buyon JP, et al
     IRF5 SLE-risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in neonatal lupus mothers.
     Arthritis Rheum. 2012 Jun 5. doi: 10.1002/art.34571.
     PubMed     Text format     Abstract available
     
     
     
167. NAMJOU B , Choi CB, Harley IT, Alarcon-Riquelme ME, et al
     Evaluation of TRAF6 in a large multiancestral lupus cohort.
     Arthritis Rheum. 2012;64:1960-9.
     PubMed     Text format     Abstract available
     
     
     May 2012
168. DEVILLIERS H , Arnaud L, Amoura Z
     Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events: comments on the article by Otomo et al.
     Arthritis Rheum. 2012 May 21. doi: 10.1002/art.34546.
     PubMed     Text format    
     
     
     
169. NIKPOUR M , Gladman DD, Ibanez D, Harvey PJ, et al
     High-sensitivity C-reactive Protein as a Markerof Cardiovascular Risk in Systemic Lupus Erythematosus.
     Arthritis Rheum. 2012 May 21. doi: 10.1002/art.34541.
     PubMed     Text format    
     
     
     
170. STEICHEN O
     A clinically relevant benefit of statins in young patients with lupus erythematosus cannot be excluded. Comment on the article by Schanberg et al.
     Arthritis Rheum. 2012 May 17. doi: 10.1002/art.34521.
     PubMed     Text format    
     
     
     
171. KONG N , Lan Q, Chen M, Wang J, et al
     Antigen-specific TGF-beta-induced regulatory T cells but not natural Tregs ameliorate autoimmune arthritis by shifting the balance of Th17 toward Treg cells.
     Arthritis Rheum. 2012 May 17. doi: 10.1002/art.34513.
     PubMed     Text format     Abstract available
     
     
     
172. WU JY , Lee SH, Shen CJ, Hsieh YC, et al
     Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: A systemic review and meta-analysis.
     Arthritis Rheum. 2012 May 17. doi: 10.1002/art.34512.
     PubMed     Text format     Abstract available
     
     
     
173. VAS J , Gronwall C, Marshak-Rothstein A, Silverman GJ, et al
     Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes.
     Arthritis Rheum. 2012 May 10. doi: 10.1002/art.34537.
     PubMed     Text format     Abstract available
     
     
     
174. PETRI M , Orbai AM, Alarcon GS, Gordon C, et al
     Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus.
     Arthritis Rheum. 2012 May 2. doi: 10.1002/art.34473.
     PubMed     Text format     Abstract available
     
     
     
175. DING S , Liang Y, Zhao M, Liang G, et al
     Decreased miR-142-3p/5p expression causes CD4(+) T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
     Arthritis Rheum. 2012 May 1. doi: 10.1002/art.34505.
     PubMed     Text format     Abstract available
     
     
     
176. CELLUCCI T , Tyrrell PN, Sheikh S, Benseler SM, et al
     Childhood primary angiitis of the central nervous system: identifying disease trajectories and early risk factors for persistently higher disease activity.
     Arthritis Rheum. 2012;64:1665-72.
     PubMed     Text format     Abstract available
     
     
     
177. BENGTSSON AA , Sturfelt G, Lood C, Ronnblom L, et al
     Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study
     Arthritis Rheum. 2012;64:1579-88.
     PubMed     Text format     Abstract available
     
     
     
178. PAWAR RD , Pitashny M, Gindea S, Tieng AT, et al
     Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.
     Arthritis Rheum. 2012;64:1620-31.
     PubMed     Text format     Abstract available
     
     
     April 2012
179. EGELSTON C , Kurko J, Besenyei T, Tryniszewska B, et al
     Suppression of dendritic cell maturation and t cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis.
     Arthritis Rheum. 2012 Apr 10. doi: 10.1002/art.34494.
     PubMed     Text format     Abstract available
     
     
     
180. WECKERLE CE , Imbuka D, Franek BS, Kelly JA, et al
     Large scale analysis of tumor necrosis factor alpha levels in systemic lupus erythematosus.
     Arthritis Rheum. 2012 Apr 5. doi: 10.1002/art.34483.
     PubMed     Text format     Abstract available
     
     
     
181. TAUROG JD , Rival C, van Duivenvoorde LM, Satumtira N, et al
     Autoimmune epididymo-orchitis is essential to the pathogenesis of male-specific spondyloarthritis in HLA-B27 transgenic rats.
     Arthritis Rheum. 2012 Apr 5. doi: 10.1002/art.34480.
     PubMed     Text format     Abstract available
     
     
     
182. LIGHTSTONE L
     The landscape after LUNAR: rituximab's crater-filled path.
     Arthritis Rheum. 2012;64:962-5.
     PubMed     Text format    
     
     
     March 2012
183. LEWIS MJ , Malik TH, Fossati-Jimack L, Carassiti D, et al
     Combining lupus and hyperlipidaemia in mice reveals distinct roles for complement in glomerulonephritis and atherosclerosis.
     Arthritis Rheum. 2012 Mar 5. doi: 10.1002/art.34451.
     PubMed     Text format     Abstract available
     
     
     
184. SAXENA A , McDonnell E, Ramos PS, Sajuthi S, et al
     Preferential transmission of genetic risk variants of candidate loci at 6p21 from asymptomatic grandparents to mothers of children with neonatal lupus.
     Arthritis Rheum. 2012;64:931-9.
     PubMed     Text format     Abstract available
     
     
     
185. GHOSH D , Kis-Toth K, Juang YT, Tsokos GC, et al
     CREMalpha suppresses spleen tyrosine kinase expression in normal but not systemic lupus erythematosus T cells.
     Arthritis Rheum. 2012;64:799-807.
     PubMed     Text format     Abstract available
     
     
     February 2012
186. DEANE K
     Learning about the natural history of rheumatoid arthritis (RA) development through prospective study of subjects at high-risk for RA-related autoimmunity.
     Arthritis Rheum. 2012 Feb 21. doi: 10.1002/art.34445.
     PubMed     Text format    
     
     
     
187. SHAPIRA I , Andrade D, Allen SL, Salmon JE, et al
     Induction of durable remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab.
     Arthritis Rheum. 2012 Feb 21. doi: 10.1002/art.34440.
     PubMed     Text format     Abstract available
     
     
     
188. BRUNNER HI , Bennett MR, Mina R, Suzuki M, et al
     Non-invasive renal protein biomarkers are associated with histological features of lupus nephritis.
     Arthritis Rheum. 2012 Feb 10. doi: 10.1002/art.34426.
     PubMed     Text format     Abstract available
     
     
     
189. CONTRERAS OE , Burdiles AJ, Vial MC, Riquelme PF, et al
     Clinical images: steroid-induced chemical synovitis.
     Arthritis Rheum. 2012;64:541.
     PubMed     Text format    
     
     
     
190. ANDREOLI L , Tincani A
     Beyond the "syndrome": antiphospholipid antibodies as risk factors.
     Arthritis Rheum. 2012;64:342-5.
     PubMed     Text format    
     
     
     
191. WALSH M , Flossmann O, Berden A, Westman K, et al
     Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis.
     Arthritis Rheum. 2012;64:542-8.
     PubMed     Text format     Abstract available
     
     
     January 2012
192. MA Y , Xu WD, Pan HF, Ye DQ, et al
     New evidence for the role of proteasome inhibitors in systemic lupus erythematosus.
     Arthritis Rheum. 2012 Jan 31. doi: 10.1002/art.34407.
     PubMed     Text format    
     
     
     
193. LOCKSHIN MD , Kim M, Laskin CA, Guerra M, et al
     Lupus anticoagulant, but not anticardiolipin antibody, predicts adverse pregnancy outcome in patients with antiphospholipid antibodies.
     Arthritis Rheum. 2012 Jan 24. doi: 10.1002/art.34402.
     PubMed     Text format     Abstract available
     
     
     
194. STOHL W , Hiepe F, Latinis KM, Thomas M, et al
     Belimumab reduces autoantibodies, normalizes low complement, and reduces select B-cell populations in patients with systemic lupus erythematosus.
     Arthritis Rheum. 2012 Jan 24. doi: 10.1002/art.34400.
     PubMed     Text format     Abstract available
     
     
     
195. PAN HF , Wang DG, Ye DQ
     APRIL in systemic lupus erythematosus: Essential or dispensable?
     Arthritis Rheum. 2012 Jan 13. doi: 10.1002/art.34388.
     PubMed     Text format    
     
     
     
196. NIELSEN CT , Ostergaard O, Stener L, Iversen LV, et al
     Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
     Arthritis Rheum. 2012 Jan 11. doi: 10.1002/art.34381.
     PubMed     Text format     Abstract available
     
     
     
197. SATOH M , Chan EK, Ho LA, Rose KM, et al
     Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.
     Arthritis Rheum. 2012 Jan 11. doi: 10.1002/art.34380.
     PubMed     Text format     Abstract available
     
     
     
198. PISETSKY DS
     Microparticles as autoantigens: Making immune complexes big.
     Arthritis Rheum. 2012 Jan 11. doi: 10.1002/art.34377.
     PubMed     Text format    
     
     
     
199. ROVIN BH , Furie R, Latinis K, Looney RJ, et al
     Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab (LUNAR) study.
     Arthritis Rheum. 2012 Jan 9. doi: 10.1002/art.34359.
     PubMed     Text format     Abstract available
     
     
     
200. LAKOS G , Favaloro EJ, Harris EN, Meroni PL, et al
     International consensus guidelines on anticardiolipin and anti-beta2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies.
     Arthritis Rheum. 2012;64:1-10.
     PubMed     Text format    
     
     
     
201. WANG H , Smith RN, Spooner AE, Isselbacher EM, et al
     Giant cell aortitis of the ascending aorta without signs or symptoms of systemic vasculitis is associated with elevated risk of distal aortic events.
     Arthritis Rheum. 2012;64:317-9.
     PubMed     Text format    
     
     
     December 2011
202. DEMORUELLE MK , Weisman MH, Simonian PL, Lynch DA, et al
     Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: Early injury or initiating site of autoimmunity?
     Arthritis Rheum. 2011 Dec 19. doi: 10.1002/art.34344.
     PubMed     Text format     Abstract available
     
     
     
203. TERRIER B , Geri G, Chaara W, Allenbach Y, et al
     IL-21 modulates Th1 and Th17 responses in giant cell arteritis.
     Arthritis Rheum. 2011 Dec 6. doi: 10.1002/art.34327.
     PubMed     Text format     Abstract available
     
     
     
204. CUDA CM , Agrawal H, Misharin AV, Haines GK 3rd, et al
     Myeloid cell-specific Fas expression is required to prevent systemic autoimmunity.
     Arthritis Rheum. 2011 Dec 5. doi: 10.1002/art.34317.
     PubMed     Text format     Abstract available
     
     
     
205. MOUNTZ JD , Li J, Hsu HC
     Systemic autoimmunity caused by Fas deficiency in macrophages - a new perspective of the first identified autoimmune gene.
     Arthritis Rheum. 2011 Dec 2. doi: 10.1002/art.34321.
     PubMed     Text format    
     
     
     
206. SREIH A , Ezzeddine R, Leng L, Lachance A, et al
     Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.
     Arthritis Rheum. 2011;63:3942-51.
     PubMed     Text format     Abstract available
     
     
     
207. RITTERHOUSE LL , Crowe SR, Niewold TB, Merrill JT, et al
     B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
     Arthritis Rheum. 2011;63:3931-41.
     PubMed     Text format     Abstract available
     
     
     
208. FURIE R , Petri M, Zamani O, Cervera R, et al
     A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
     Arthritis Rheum. 2011;63:3918-30.
     PubMed     Text format     Abstract available
     
     
     
209. LAL P , Su Z, Holweg CT, Silverman GJ, et al
     Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
     Arthritis Rheum. 2011;63:3681-91.
     PubMed     Text format     Abstract available
     
     
     
210. BIZZARO N , Tonutti E, Villalta D
     Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEP-2 cells: not an easy task! Comment on the article by Mariz et al.
     Arthritis Rheum. 2011;63:4036-7.
     PubMed     Text format    
     
     
     
211. CROW YJ
     Lupus: how much "complexity" is really (just) genetic heterogeneity?
     Arthritis Rheum. 2011;63:3661-4.
     PubMed     Text format    
     
     
     
212. MONACH PA , Tomasson G, Specks U, Stone JH, et al
     Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.
     Arthritis Rheum. 2011;63:3988-97.
     PubMed     Text format     Abstract available
     
     
     
213. DE LAAT B , van Berkel M, Urbanus RT, Siregar B, et al
     Immune responses against domain I of beta(2)-glycoprotein I are driven by conformational changes: domain I of beta(2)-glycoprotein I harbors a cryptic immunogenic epitope.
     Arthritis Rheum. 2011;63:3960-8.
     PubMed     Text format     Abstract available
     
     
     November 2011
214. WINCHESTER R , Wiesendanger M, Zhang HZ, Steshenko V, et al
     Immunologic characteristics of intrarenal T cells: Trafficking of expanded CD8 T cell beta-chain clonotypes in progressive lupus nephritis.
     Arthritis Rheum. 2011 Nov 30. doi: 10.1002/art.33488.
     PubMed     Text format     Abstract available
     
     
     
215. SMITH S , Gabhann JN, Higgs R, Stacey K, et al
     Enhanced interferon regulatory factor 3 binding to the IL-23p19 promoter correlates with enhanced IL-23 expression in systemic lupus erythematosus.
     Arthritis Rheum. 2011 Nov 29. doi: 10.1002/art.33494.
     PubMed     Text format     Abstract available
     
     
     
216. JACOB CO , Guo S, Jacob N, Pawar RD, et al
     Dispensability of APRIL to development of systemic lupus erythematosus in NZM 2328 mice.
     Arthritis Rheum. 2011 Nov 29. doi: 10.1002/art.33458.
     PubMed     Text format     Abstract available
     
     
     
217. JOG NR , Frisoni L, Shi Q, Monestier M, et al
     Caspase-activated DNase is required to maintain tolerance to lupus nuclear autoantigens.
     Arthritis Rheum. 2011 Nov 29. doi: 10.1002/art.33448.
     PubMed     Text format     Abstract available
     
     
     
218. XU WD , Zhang YJ, Li R, Pan HF, et al
     New evidence for the role of MICA in the pathogenesis of systemic lupus erythematosus: Comment on the article by Yoshida et al.
     Arthritis Rheum. 2011 Nov 11. doi: 10.1002/art.33456.
     PubMed     Text format    
     
     
     
219. LYLES GW , Moyer S, Chavala SH
     Peripheral retinal neovascularization in anti-phospholipid antibody syndrome.
     Arthritis Rheum. 2011 Nov 10. doi: 10.1002/art.33469.
     PubMed     Text format    
     
     
     
220. BRENNER M , Laragione T, Shah A, Mello A, et al
     Identification of two new arthritis severity loci that regulate levels of autoantibodies, IL-1beta and joint damage.
     Arthritis Rheum. 2011 Nov 10. doi: 10.1002/art.33468.
     PubMed     Text format     Abstract available
     
     
     
221. YU B , Guan M, Peng Y, Shao Y, et al
     Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus.
     Arthritis Rheum. 2011;63:3487-92.
     PubMed     Text format     Abstract available
     
     
     
222. LINDOP R , Arentz G, Chataway TK, Thurgood LA, et al
     Molecular signature of a public clonotypic autoantibody in primary Sjogren's syndrome: A "forbidden" clone in systemic autoimmunity.
     Arthritis Rheum. 2011;63:3477-86.
     PubMed     Text format     Abstract available
     
     
     October 2011
223. DWIVEDI N , Upadhyay J, Neeli I, Khan S, et al
     Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular traps.
     Arthritis Rheum. 2011 Oct 27. doi: 10.1002/art.33432.
     PubMed     Text format     Abstract available
     
     
     
224. MEHTA J , Cron RQ
     NFATc1 (NFAT2) is increased in murine and human lupus T cells.
     Arthritis Rheum. 2011 Oct 27. doi: 10.1002/art.33442.
     PubMed     Text format    
     
     
     
225. SCHANBERG LE , Sandborg C, Barnhart HX, Ardoin SP, et al
     Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
     Arthritis Rheum. 2011 Oct 26. doi: 10.1002/art.30645.
     PubMed     Text format     Abstract available
     
     
     
226. RAVELLI A
     Should children and adolescents with systemic lupus erythematosus be given statin therapy to prevent early atherosclerosis?
     Arthritis Rheum. 2011 Oct 26. doi: 10.1002/art.30642.
     PubMed     Text format    
     
     
     
227. KATRIN M , Kalies K, Szyska M, Humrich JY, et al
     CXCR3 promotes the production of IgG1 (auto)antibodies but is not essential for the development of lupus nephritis in NZB/W mice.
     Arthritis Rheum. 2011 Oct 17. doi: 10.1002/art.33424.
     PubMed     Text format     Abstract available
     
     
     
228. ROCHA OLIVEIRA PC , Martins BJ
     Infarct-associated bone sarcoma in the clinical context of systemic lupus erythematosus.
     Arthritis Rheum. 2011 Oct 17. doi: 10.1002/art.33421.
     PubMed     Text format    
     
     
     
229. BALDINI M , Maugeri N, Ramirez GA, Giacomassi C, et al
     Selective upregulation of the soluble pattern recognition receptor PTX3 and of VEGF in giant cell arteritis: Relevance for recent optic nerve ischemia.
     Arthritis Rheum. 2011 Oct 11. doi: 10.1002/art.33411.
     PubMed     Text format     Abstract available
     
     
     
230. FUJIMOTO M , Hamaguchi Y, Kaji K, Matsushita T, et al
     Myositis-specific anti-155/140 autoantibodies target transcriptional intermediary factor 1 family proteins.
     Arthritis Rheum. 2011 Oct 10. doi: 10.1002/art.33403.
     PubMed     Text format     Abstract available
     
     
     
231. FIORENTINO D , Casciola-Rosen L
     TIF1 autoantibodies in dermatomyositis shed insight into the cancer-myositis connection.
     Arthritis Rheum. 2011 Oct 10. doi: 10.1002/art.33402.
     PubMed     Text format    
     
     
     
232. WATANABE T , Yamashita K, Fujikawa S, Sakurai T, et al
     Activation of toll-like receptors and NOD-like receptors is involved in enhanced IgG4 responses in autoimmune pancreatitis.
     Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33386.
     PubMed     Text format     Abstract available
     
     
     
233. TRENDELENBURG M
     Anti-C1q as a diagnostic marker of proliferative lupus nephritis: Comment on the article by Katsumata Y et al (pages 2436-2444).
     Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33384.
     PubMed     Text format    
     
     
     
234. COLASANTI T , Maselli A, Conti F, Sanchez M, et al
     Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.
     Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33400.
     PubMed     Text format     Abstract available
     
     
     
235. STONE RC , Feng D, Deng J, Singh S, et al
     IRF5 activation in monocytes of SLE patients is triggered by circulating autoantigens independent of type I IFN.
     Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33395.
     PubMed     Text format     Abstract available
     
     
     
236. DREYER L , Faurschou M, Mogensen M, Jacobsen S, et al
     High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: A long-term followup study in a Danish cohort.
     Arthritis Rheum. 2011;63:3032-7.
     PubMed     Text format     Abstract available
     
     
     September 2011
237. TRALLERO-ARAGUAS E , Rodrigo-Pendas JA, Selva-O'Callaghan A, Martinez-Gomez X, et al
     Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33379.
     PubMed     Text format     Abstract available
     
     
     
238. ARCAND J , Robitaille G, Koenig M, Senecal JL, et al
     The autoantigen DNA topoisomerase I interacts with chemokine receptor 7 and exerts cytokine-like effects on dermal fibroblasts.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33377.
     PubMed     Text format     Abstract available
     
     
     
239. GOLDENBERG D , Miller E, Perna M, Sattar N, et al
     The relationship between n-terminal pro-brain natriuretic peptide and markers of cardiac and vascular disease in systemic lupus erythematosus patients.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33374.
     PubMed     Text format    
     
     
     
240. OTOMO K , Atsumi T, Amengual O, Fujieda Y, et al
     The efficacy of antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33340.
     PubMed     Text format     Abstract available
     
     
     
241. RESTUCCIA G , Cavazza A, Boiardi L, Pipitone N, et al
     Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculits of the temporal artery: Two subsets of giant cell arteritis.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33362.
     PubMed     Text format     Abstract available
     
     
     
242. KINLOCH AJ , Alzabin S, Brintnell W, Wilson E, et al
     Immunisation with Porphyromonas gingivalis enolase induces autoimmunity to mammalian alpha-enolase and arthritis in DR4-IE transgenic mice.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.30639.
     PubMed     Text format     Abstract available
     
     
     
243. XU WD , Zhang YJ, Ye DQ
     Evidence for the role of miR-146a in the pathogenesis of systemic lupus erythematosus with atherosclerosis.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33356.
     PubMed     Text format    
     
     
     
244. HUGHES T , Adler A, Kelly JA, Kaufman KM, et al
     Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.
     Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33354.
     PubMed     Text format     Abstract available
     
     
     
245. BACON P
     New etiopathogenic knowledge, or politics? Comment on the article by Falk et al.
     Arthritis Rheum. 2011;63:2836-7.
     PubMed     Text format    
     
     
     
246. SAKELLARIOU GT , Karanikolas D, Kapetanos GA, Koutroumanidis K, et al
     Clinical images: Extensive calcinosis in lupus panniculitis.
     Arthritis Rheum. 2011;63:2743.
     PubMed     Text format    
     
     
     
247. TAN W , Sunahori K, Zhao J, Deng Y, et al
     Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.
     Arthritis Rheum. 2011;63:2755-63.
     PubMed     Text format     Abstract available
     
     
     August 2011
248. GONO T , Takarada T, Fukumori R, Kawaguchi Y, et al
     NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus erythematosus.
     Arthritis Rheum. 2011 Aug 30. doi: 10.1002/art.30616.
     PubMed     Text format     Abstract available
     
     
     
249. CONIGLIARO P , Benson RA, Patakas A, Kelly SM, et al
     Characterization of the anticollagen antibody response in a new model of chronic polyarthritis.
     Arthritis Rheum. 2011;63:2299-308.
     PubMed     Text format     Abstract available
     
     
     
250. HOU LF , He SJ, Li X, Yang Y, et al
     Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
     Arthritis Rheum. 2011;63:2445-55.
     PubMed     Text format     Abstract available
     
     
     May 2011
251. ANDRADE D , Redecha PB, Vukelic M, Qing X, et al
     Engraftment of PBMC from SLE and APS donors into BALB-Rag2-/-IL2Rgc-/- mice: A promising model for studying human disease.
     Arthritis Rheum. 2011 May 10. doi: 10.1002/art.30424.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: